Bone tissue engineering with novel rhBMP2-PLLA composite scaffolds.

The aims of the present study were to fabricate a novel porous polylactic acid (PLLA) composite scaffold and evaluate the capacity of the scaffold in carrying recombinant bone morphogenetic protein 2 (rhBMP2) for engineering bone formation. The structures of the PLLA scaffolds were evaluated by SEM and the controlled release of rhBMP2 from the composite scaffolds was assayed by ELISA. Bone induction by the scaffolds loaded with or without rhBMP2 was performed in the calf muscle of twenty Wistar rats for 3, 7, 10, 14, and 28 days. Tissue specimens were examined by Masson's trichrome and von Kossa stainings, and immunohistochemistry of bone proteins. Our results indicated that a moderate foreign body reaction was found in control scaffolds, which lasted for 4 weeks. The addition of rhBMP2 to this novel scaffold dramatically alleviated the adverse responses to PLLA. Enhanced deposition of collagen matrix and endochondral formation were observed in rhBMP2-PLLA scaffolds at 7-10 days, compatible with an early release of rhBMP2 in the composite scaffolds. Bone sialoprotein and osteopontin were demonstrated simultaneously. Von Kossa staining was observed in the test group at 10-14 days. In conclusion, the PLLA scaffolds exhibited the capability of carrying rhBMP2 for inducing bone formation within 2 weeks. These results suggest that rhBMP2-PLLA scaffold may be applicable in tissue engineering.

[1]  T. Park,et al.  Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. , 1999, Journal of biomedical materials research.

[2]  M C Davies,et al.  A novel biotinylated degradable polymer for cell-interactive applications. , 1998, Biotechnology and bioengineering.

[3]  P. Trisi,et al.  Histochemical and confocal laser scanning microscopy study of the bone-titanium interface: an experimental study in rabbits. , 1994, Biomaterials.

[4]  C. Praul,et al.  Confocal imaging and timing of secretion of matrix proteins by osteoblasts derived from avian long bone. , 2000, Comparative biochemistry and physiology. Part A, Molecular & integrative physiology.

[5]  V. Rosen,et al.  Recombinant human bone morphogenetic protein induces bone formation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  K. Ishihara,et al.  Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer. , 1996, Journal of biomedical materials research.

[7]  J C Petit,et al.  Periodontal tissue regeneration by combined applications of recombinant human osteogenic protein-1 and bone morphogenetic protein-2. A pilot study in Chacma baboons (Papio ursinus). , 2001, European journal of oral sciences.

[8]  A. Reddi,et al.  TRANSFORMATION OF FIBROBLASTS BY ALLOGENEIC AND XENOGENEIC TRANSPLANTS OF DEMINERALIZED TOOTH AND BONE , 1970, The Journal of experimental medicine.

[9]  J. Wozney,et al.  Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. , 1999, Journal of biomedical materials research.

[10]  J. Wozney,et al.  Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo. , 1999, Journal of biomedical materials research.

[11]  A. Wetterwald,et al.  Expression of matrix proteins during the development of mineralized tissues. , 1996, Bone.

[12]  M. Young,et al.  Expression of bone sialoprotein (BSP) in developing human tissues , 1991, Calcified Tissue International.

[13]  J. Feijen,et al.  Interaction of cultured human endothelial cells with polymeric surfaces of different wettabilities. , 1985, Biomaterials.

[14]  C. Lao,et al.  Polymer-assisted regeneration therapy with Atrisorb barriers in human periodontal intrabony defects. , 2004, Journal of clinical periodontology.

[15]  S. Bruder,et al.  Mesenchymal stem cells in bone development, bone repair, and skeletal regenaration therapy , 1994 .

[16]  T. Hsien,et al.  Preparation and characterization of RGD-immobilized chitosan scaffolds. , 2005, Biomaterials.

[17]  J. Wozney,et al.  Augmentation of Alveolar Bone and Dental Implant Osseointegration: Clinical Implications of Studies with rhBMP-2 A Comprehensive Review , 2001, The Journal of bone and joint surgery. American volume.

[18]  Charles A Vacanti,et al.  Tissue engineering: The first decade and beyond , 1998, Journal of cellular biochemistry.

[19]  M. Somerman,et al.  Bone morphogenetic proteins secreted by breast cancer cells upregulate bone sialoprotein expression in preosteoblast cells. , 2000, Experimental cell research.

[20]  J. Triffitt.  Initiation and enhancement of bone formation. A review. , 1987, Acta orthopaedica Scandinavica.

[21]  V. Lefebvre,et al.  Regulatory mechanisms in the pathways of cartilage and bone formation. , 2001, Current opinion in cell biology.

[22]  M. Urist.  Bone: Formation by Autoinduction , 1965, Science.

[23]  T. Ushida,et al.  Preparation of poly(L-lactic acid) and poly(DL-lactic-co-glycolic acid) foams by use of ice microparticulates. , 2001, Biomaterials.

[24]  K. Takaoka,et al.  Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. , 1992, Clinical orthopaedics and related research.

[25]  G. Moonen,et al.  Preparation of a macroporous biodegradable polylactide implant for neuronal transplantation. , 1995, Journal of biomedical materials research.

[26]  J. Lian,et al.  Induction of bone‐related proteins, osteocalcin and osteopontin, and their matrix ultrastructural localization with development of chondrocyte hypertrophy in vitro , 1993, Journal of cellular biochemistry.

[27]  R. Friedman,et al.  Pre-clinical in vivo evaluation of orthopaedic bioabsorbable devices. , 2000, Biomaterials.

[28]  R. Delamarter,et al.  Effective Doses of Recombinant Human Bone Morphogenetic Protein‐2 in Experimental Spinal Fusion , 1996, Spine.

[29]  J. Aubin,et al.  Osteoblast and chondroblast differentiation. , 1995, Bone.

[30]  J. Feijen,et al.  The effect of phagocytosis of poly(L-lactic acid) fragments on cellular morphology and viability. , 1993, Journal of biomedical materials research.

[31]  J. Wozney,et al.  Bone Formation with Use of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2)* , 1997, The Journal of bone and joint surgery. American volume.

[32]  Juin-Yih Lai,et al.  Preparation of porous scaffolds by using freeze-extraction and freeze-gelation methods. , 2004, Biomaterials.

[33]  H. Gruber,et al.  Adaptations of Goldner's Masson trichrome stain for the study of undecalcified plastic embedded bone. , 1992, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[34]  K. Kusumoto,et al.  Comparison of recombinant and purified human bone morphogenetic protein. , 1999, The British journal of oral & maxillofacial surgery.

[35]  A. Ryan,et al.  Processing of Poly(2,6-dimethyl-1,4-phenylene ether) with Epoxy Resin. 1. Reaction-Induced Phase Separation , 2000 .

[36]  J. Wozney,et al.  Periodontal repair in dogs: evaluation of rhBMP-2 carriers. , 1996, The International journal of periodontics & restorative dentistry.

[37]  M. Sakuda,et al.  Sequential progression of the differentiation program by bone morphogenetic protein-2 in chondrogenic cell line ATDC5. , 1998, Experimental cell research.

[38]  Seung Jin Lee,et al.  Porous poly(l-lactide) membranes for guided tissue regeneration and controlled drug delivery: membrane fabrication and characterization , 1997 .

[39]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988 .

[40]  Martyn C. Davies,et al.  Surface engineering of poly(lactic acid) by entrapment of modifying species , 2000 .

[41]  K. Shakesheff,et al.  Human osteoprogenitor growth and differentiation on synthetic biodegradable structures after surface modification. , 2001, Bone.

[42]  J. Heckman,et al.  The use of bone morphogenetic protein in the treatment of non-union in a canine model. , 1991, The Journal of bone and joint surgery. American volume.